Phase I Trial of Intratumoral Bi-functional shRNA Stathmin 1-knockdown Lipoplex in Patients With Advanced and/or Metastatic Cancer.

Trial Profile

Phase I Trial of Intratumoral Bi-functional shRNA Stathmin 1-knockdown Lipoplex in Patients With Advanced and/or Metastatic Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Anti-stathmin gene therapy (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Sponsors Gradalis; Strike Bio
  • Most Recent Events

    • 24 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 07 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Jul 2017, as reported by ClinicalTrials.gov.
    • 07 Apr 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Mar 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top